Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Lung Cancer Health Center

Font Size

Lung Cancer Genes Raise Treatment Hopes

Huge Lung-Cancer Gene Study Points to New Treatment Targets
WebMD Health News
Reviewed by Louise Chang, MD

Oct. 22, 2008 -- A huge study funded by the National Institutes of Health triples the number of genes linked to lung cancer and points toward new treatments.

The study analyzed DNA sequences from 623 genes in tumor samples from 188 patients with lung adenocarcinoma, the most common form of lung cancer.

The study turned up 26 genes mutated at high frequency in lung cancer tumors. Previously, 10 gene mutations had been linked to lung cancer -- and only five of them were known to be mutated at high frequency.

Tumors from smokers carried as many as 49 mutations. No tumor from nonsmokers had more than five mutations.

More than two-thirds of the tumors carried a mutation in a gene affecting a chemical pathway called mitogen-activated protein kinase or MAPK. This suggests that a group of compounds that affect the MAPK pathway -- the MEK inhibitors -- may be particularly effective. These compounds show promise in a mouse model of colon cancer.

The findings also raise hopes for an existing drug. Rapamycin, approved for use in organ transplants and kidney cancer, affects the mTOR chemical pathway. Nearly a third of the lung tumors analyzed in the gene study affected the mTOR pathway.

"Our work uncovered many new targets for therapy of this deadly disease," MIT and Harvard researcher Matthew Meyerson, MD, PhD, says in a news release.

The findings appear in the Oct. 23 issue of the journal Nature.

Today on WebMD

Broken cigarette
Do you know the myths from the facts?
man with a doctor
Our health check will steer you in the right direction.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Lung cancer xray
See it in pictures, plus read the facts.
15 Cancer Symptoms Men Ignore
Lung Cancer Risks Myths and Facts
cancer fighting foods
Improving Lung Cancer Survival Targeted Therapy
Lung Cancer Surprising Differences Between Sexes
Pets Improve Your Health
Vitamin D
Lung Cancer Surgery Options